BioMed Research International
Volume 2019 (2019), Article ID 9765253, 11 pages
https://doi.org/10.1155/2019/9765253

Research Article

Clinical Characteristics of 1378 Inpatients with Spinal Tuberculosis in General Hospitals in South-Central China

Zheng Liu,1,2 Jun Wang,1,2 Gong-Zhou Chen,1,2 Wei-Wei Li,1,2 Yun-Qi Wu,² Xiao Xiao,1,2 Yi-Lu Zhang,² Yan Yang,1,2 Wen-Kai Hu,1,2 Zhi-Cheng Sun,1,2 and Xi-Yang Wang1,2

¹Department of Spine Surgery, Xiangya Hospital, Central South University, 87#Xiangya Road, Changsha 410008, Hunan, China
²Hunan Engineering Laboratory of Advanced Artificial Osteo-materials, Xiangya Hospital, Central South University, 87#Xiangya Road, Changsha 410008, Hunan, China

Correspondence should be addressed to Xi-Yang Wang; wqlwqwxy@163.com

Received 15 December 2018; Accepted 11 February 2019; Published 3 March 2019

Academic Editor: Frederick D. Quinn

Copyright © 2019 Zheng Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

In this retrospective study, charts of inpatients with spinal tuberculosis (STB) treated in large-scale general hospitals in Changsha, Hunan, China, between 2007 and 2016 were reviewed to investigate their clinical characteristics. Demographic, epidemiological and clinical features, imaging findings, treatment methods, and prognosis were summarized and analyzed. There were 1378 patients, 805 males and 573 females, with a mean age of 43.7 years. The mean interval between symptom onset and diagnosis was 16.0 months (range 15 days–240 months). The incidence of back pain, radicular pain and symptoms of systemic toxicity was 92.5%, 40.1%, and 32.1%, respectively. The rate of neurological impairment was 49.9 %. STB was present in two or more vertebrae in 91.1% of patients, with two adjacent vertebrae being involved in 67.9% of them. The lumbar segment (38.2%) was the most frequently affected, followed by the thoracic spine (35.7%). The sacrococcygeal area was the least frequently involved (0.8%). Abscesses were detected in 65.5% of patients. One thousand patients (72.6%) were managed with surgery and 378 (27.4%) with anti-TB drugs only. Cure was achieved in 1215 patients (88.2%), whereas 49 (3.5 %) had relapses. Concomitant pulmonary TB (PTB) was diagnosed in 366 patients (26.6%) and 63 (4.6%) had concomitant diabetes. Compared with the previous five years, the number of older patients, urban patients, and medical staff with STB had increased by 6.1%, 5.2%, and 1.3%, respectively in the five years studied. STB remains a severe public health problem that cannot be ignored. Most of the patients ignored early symptoms and therefore received untimely treatment. Thus, surveillance for and treatment of STB in South-central China requires strengthening. In addition to the current China-wide database of patients with PTB, a China-wide database of patients with STB should also be set up.

1. Introduction

According to a 2018 report of the World Health Organization (WHO) [1], although the incidence and mortality of tuberculosis (TB) in China have been declining slowly in recent years, China still had the second highest burden of TB in the world, with about 889,000 new cases of TB and 388,000 deaths in 2017, second only to India. Thus, TB is still a major problem, endangering the health of Chinese people.

Spinal tuberculosis (STB), which accounts for half of bone and joint TB and is the most common form of extrapulmonary TB, often leads to irreversible neurological injury, including paralysis, resulting in serious social and economic problems [2]. STB is a chronic disease that is slowly progressive, and diagnosing it is relatively difficult [3].

Progression of STB may cause spinal deformity and neurological injury, including paralysis, which seriously affect the quality of lives of affected patients and are difficult to cure by chemotherapy drugs. Anti-TB drug chemotherapy is the major means of treating STB and is the fundamental means of curing STB, with surgery being an adjuvant means of treatment [4, 5].

Clinical data concerning TB differ according to differences in geographical locations, life style, level of economic development, level of available medical services, and other factors. In Hunan province, located in south-central China, there is a high incidence (83.0/10 million) and high number of reported cases (55,919 cases) of pulmonary tuberculosis (PTB), resulting in this province ranking in the top eight and three provinces of China, respectively (data obtained from the notifiable PTB report of the Chinese Infectious Disease Report System [IDRS]). A number of epidemiological studies of PTB in Hunan have been published, but none concerning STB. This is also true for throughout China.

In this study, clinical data of inpatients with STB in Changsha, Hunan, from 2007 to 2016, including general information, symptoms of TB, diagnosis, treatment, and prognosis, were collected and analyzed to help in the prevention, diagnosis, treatment, and prognosis of STB in Hunan province.

2. Materials and Methods

2.1. Patients Survey

In this retrospective study, the medical records of inpatients admitted for STB to several large comprehensive hospitals in Changsha, Hunan, China, from January 2007 to December 2016 were collected and reviewed.

Diagnosis of STB was established by clinical, laboratory, and imaging investigations supplemented by pathological examination of biopsy specimens. The diagnosis was based on the following criteria: clinical symptoms and signs such as backache, spinal deformity, neurological deficit (numbness, weakness, dysesthesia, dyskinesia, and paralysis), systemic toxicity symptoms (STS) of TB, including low-grade fever, night sweats and emaciation; computed tomography (CT) and magnetic resonance imaging (MRI) manifestations, such as destruction of vertebral bone, intervertebral space involvement, kyphosis, paravertebral abscess formation, and dural sac compression; laboratory findings including high erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) concentration, positive T-SPOT, TB antibody (IgG and IgM), and tuberculin test; diagnostic anti-TB treatment was effective when it was difficult to otherwise make a definite diagnosis; pathological evidence of TB, such as typical TB with caseous necrosis microscopically, was regarded as the golden standard of diagnosis.

All patients who were diagnosed with STB were routinely treated with the HREZ anti-TB chemotherapy regimen for 12–18 months, namely, rifampicin (450 mg/day), isoniazid (300 mg/day), ethambutol (750 mg/day), and pyrazinamide (750 mg/day). Kidney function and liver function were monitored during anti-TB chemotherapy.

Indications for surgery for STB were as follows: progressive or severe neurological damage, bone destruction of various degrees with severe or developing spinal deformity, persistent back pain due to spinal instability, and poor response to medical treatment.

2.2. Clinical Data

On hospital admission, personal characteristics, clinical manifestations, imaging findings, comorbidities, treatment, and prognostic indicators were collected and analyzed. Patients with missing personal, clinical, or examination data were excluded from the study. Detailed clinical data, including sex, age, place of residence (rural versus urban), occupation, local pain, radicular pain, STS, abscess, neurological injury, involved vertebrae, locations of lesions, concomitant PTB or diabetes, and treatment, were summarized. The American Spinal Injury Association (ASIA) impairment scale was applied to score neurological function. Correlations between variables and years of study were analyzed.

Patients with STB were divided into two groups according to the year of admission, Group A from January 2007 to December 2011 and Group B from January 2012 to December 2016, and variables were assessed comparing the two groups. Trends in changes of each variable were summarized. Because STB is considered to originate from PTB and diabetes is a common comorbidity of STB, correlations between PTB, diabetes, and STB were analyzed.

Follow-up information was obtained by telephone, through e-mail, and during return visits to the outpatient department. “Cure” was defined as follows: no recurrence of TB lesions within 2 years after treatment, maintenance of ESR within the normal range, identification of bone union in lesions by radiographic examination, and disappearance of clinical symptoms for 3 months.[6]

2.3. Statistical Analysis

Statistical analysis of the experimental data was performed with the χ² test using SPSS 24.0 software (SPSS, Chicago, IL, USA). P < 0.05 was considered to denote significant differences.

3. Results

3.1. Demographic, Epidemiological, and Personal Characteristics

During the years of this study, there were 1378 eligible inpatients with STB. Table 1 shows the demographic, epidemiological, and personal characteristics of the study patients. During this 10-year period, the incidence of STB was relatively stable (116–170 new cases per year). The study cohort comprised 805 (58.4%) male and 573 (41.6%) female patients. In the 10 years of the study, there were always more male than female patients. Additionally, there was no significant difference in the ratio of male to female during these 10 years (P > 0.05).

Table 1: Demographics and epidemiology of inpatients with STB.

Year
Gender
Age (yeas)
Residence
Occupation
Total

Male
Female
<18
18~45
46~60
>60
Rural
Urban
Farmer
Worker
Student
Others

2007
70
46
7
53
42
14
84
32
59
24
10
23
116

2008
82
56
11
58
41
28
96
42
67
30
12
29
138

2009
65
58
15
52
33
23
91
32
65
22
16
20
123

2010
86
60
10
66
38
32
122
24
75
24
14
33
146

2011
75
56
6
61
33
31
101
30
71
21
9
30
131

2012
91
60
10
71
31
39
115
36
69
30
13
39
151

2013
79
69
13
59
43
33
99
49
65
28
14
41
148

2014
75
46
6
42
47
26
76
45
56
21
7
47
121

2015
101
69
11
63
46
50
122
48
79
27
17
47
170

2016
81
53
11
36
49
38
97
37
53
32
16
33
134

Total
805
573
100
561
403
314
1003
375
659
259
128
332
1378

Rate (%)
58.4
41.6
7.3
40.7
29.2
22.8
72.8
27.2
47.8
18.8
9.3
24.1

χ2
4.583
46.592
20.252
30.756

P
0.869
0.011
0.016

0.281

The age range was 1–88 years, with the mean age being 43.7 years. Specifically, 561 patients (40.7%) were aged from 18 to 45 years, followed by the 46–60 years-old (27.2%). As to place of residence, urban patients accounted for 29.2% (375/1378) and rural patients 72.8% (1003/1378) of the cohort. The mean interval between symptom onset and diagnosis in the hospital was 16.0 months (range 15 days–240 months), this interval being a mean of 22.0 months in rural patients and 9.6 months in urban patients; this difference is significant (P<0.05). In addition, the distribution of patients with STB in various cities of Hunan province is shown in Figure 1 (Changsha, 15.53%; Shaoyang, 11.68%; Yueyang, 9.43%; Yiyang, 9.29%; Loudi, 8.78%; Yongzhou, 8.06%; Hengyang, 6.68%; Zhuzhou, 6.46%; Changde, 5.95%; Xiangtan, 3.70%; Zhangjiajie, 3.05%; Chenzhou, 2.18%; Huaihua, 2.98%; Xiangxi, 1.89%). The remaining 4.35% were from Jiangxi and Guizhou province, both adjoining Hunan province.

Figure 1: The distribution of patients with STB in Hunan province is shown: 214 (15.53%) were from Changsha (J), 161 (11.68%) from Shaoyang (G), 130 (9.43%) from Yueyang (D), 128 (9.29%) from Yiyang (E), 121 (8.78%) from Loudi (H), 111 (8.06%) from Yongzhou (M), 92 (6.68%) from Hengyang (L), 89 (6.46%) from Zhuzhou (K), 82 (5.95%) from Changde (C), 51(3.70%) from Xiangtan (I), 42 (3.05%) from Zhangjiajie (B), 30 (2.18%) from Chenzhou (N), 41 (2.98%) from Huaihua (F), and 26 (1.89%) from Xiangxi (A).

As to distribution of occupations, there were 659 farmers (47.8%), 259 manual workers (18.8%), 128 students (9.3%), and 332 with other occupations (24.1%). The correlation between occupations and years `was analyzed. Distribution of occupation did not differ significantly over time (P > 0.05).

3.2. Clinical Presentation

As to the clinical presentation of patients with STB (Table 2), 92.5% presented with back pain and the remaining 7.5% with spinal deformity or numbness in the limbs without back pain. The incidences of radicular pain and STS in patients with STB were 40.1% and 32.1%, respectively. Analysis of correlations between back pain and radicular pain and year of study showed no significant change in the incidence of these symptoms over the 10 years (P > 0.05). As to distribution of severity of neurological injury, 21 (1.5%) patients had ASIA Grade A deficits, 38 (2.8%) Grade B, 111 (8.1%) Grade C, 517 (37.5%) Grade D, and 691 (50.1%) Grade E.

Table 2: Clinical presentation of inpatients with STB.

Year
Back pain
Radiating pain
Systemic toxicity symptoms
Neurological injury

(ASIA grade)

Yes
No
Yes
No
Yes
No
A
B
C
D
E

2007
108
8
55
61
38
78
2
3
6
50
55

2008
127
11
60
78
47
91
1
2
10
58
67

2009
109
14
49
74
39
84
2
2
14
40
65

2010
134
12
51
95
44
102
1
3
13
64
65

2011
118
13
49
82
47
84
3
2
13
50
63

2012
142
9
52
99
66
85
4
5
12
52
78

2013
139
9
59
89
37
111
2
6
8
61
71

2014
116
5
56
65
29
92
1
3
11
33
73

2015
154
16
56
114
52
118
2
6
9
52
101

2016
128
6
65
69
44
90
3
6
15
57
53

Total
1275
103
552
826
443
935
21
38
111
517
691

Rate (%)
92.5
7.5
40.1
59.9
32.1
67.9
1.5
2.8
8.1
37.5
50.1

χ2
9.607
16.782
18.017
26.902

P
0.383
0.052
0.035
0.081

3.3. Imaging Findings

As shown in Table 3, the lumbar segment was the most frequently affected site (38.2%), followed by the thoracic (35.7%), lumbosacral (8.0%), thoracolumbar (7.9%), cervical (6.4%), and cervicothoracic spines (3.0%), the sacrococcygeal area being the least frequently involved (0.8%). There was STB in two or more vertebrae in 91.1% of patients, in 67.9% of whom two adjacent vertebrae were involved. Abscesses were detected by CT or MRI in 903 of 1378 patients (65.5%), including paraspinal, prevertebral and psoas abscesses.

Table 3: Imaging findings of inpatients with STB.

Year
Lesion sites
Involved number of vertebrae
Abscess

C
CT
T
TL
L
LS
S
1
2
≧3
With
Without

2007
6
5
53
7
39
6
0
10
81
25
75
41

2008
8
8
59
11
40
11
1
16
92
30
87
51

2009
5
4
49
16
39
9
1
12
86
25
80
43

2010
11
3
59
12
47
13
1
17
104
25
98
48

2011
2
7
52
12
47
9
2
6
85
40
89
42

2012
8
1
55
10
60
14
3
13
101
37
109
42

2013
11
3
49
9
68
8
0
14
97
37
90
58

2014
12
2
28
14
52
12
1
10
79
32
81
40

2015
12
2
53
10
80
11
2
15
124
31
112
58

2016
13
6
35
8
55
17
0
10
86
38
82
52

Total
88
41
492
109
527
110
11
123
935
320
903
475

Rate (%)
6.4
3.0
35.7
7.9
38.2
8.0
0.8
8.9
67.9
23.2
65.5
34.5

χ2
81.027
17.655
6.582

P
0.01
0.479
0.681

C: Cervical; CT: Cervicothoracic; T: Thoracic; TL: Thoracolumbar; L: Lumbar; LS: Lumbosacral; S: Sacrococcygeal.

3.4. Treatment and Prognosis

As to distribution of treatment (Figure 2), 1000 patients (72.6%) were treated surgically and 378 (27.4%) with anti-TB drugs only. The proportion of patients undergoing surgery did not differ significantly over the 10 years of the study (P > 0.05). The surgical approach (single anterior, single posterior, or combined anterior–posterior approach) was selected on the basis of each patient’s condition. Minimally invasive CT-guided percutaneous catheter drainage and focal catheter infusion was used in patients with huge iliopsoas abscesses; these procedures are included in the surgical group.

Figure 2: Number of patients treated by surgery or anti-TB chemotherapy only in each year.

As to distribution of prognosis (Figure 3), 1215 patients (88.2%) gradually achieved cure within 18 months after hospital admission and initiation of treatment. The 49 patients (3.5%) who relapsed all had postoperative recurrences and required retreatment in hospital. Relapses were presented as postoperative recurrence of TB lesions, abscess formation, sinus formation, progressive kyphosis, or internal fixation fractures, all of which were treated by revision surgery. Follow-up data on the other 114 patients (8.3%) were incomplete. They included patients who were transferred to specialized TB hospitals, those with lost contact, those not cured, and those who died. Poor compliance was the main reason for patients not achieving cure. One death was due to systemic infection.

Figure 3: Number of patients with various outcomes in each year.

3.5. Comorbidities

Concomitant PTB, including a previous history of PTB, was present in 366 (26.6%) patients (Figure 4), whereas 63 patients (4.6%) had concomitant diabetes (Figure 5). The proportion of patients with STB accompanied by PTB or diabetes did not differ significantly over the 10 study years (P > 0.05). Among other complications, two patients with thoracolumbar STB had accompanying renal TB and one with cervical STB had accompanying lymph node TB. None of the patients in this study were HIV-positive.

Figure 4: Number of patients with and without concomitant PTB in each year.

Figure 5: Number of patients with and without concomitant diabetes in each year.

Correlations between various variables and STB and PTB are shown in Table 4. Of the patients with PTB, 63.4% were males, 70.8% had accompanying abscesses, 37.7% had STS, 56.6% had accompanying neurological damage, and 61.2% received non-surgical treatment only. Sex, abscess, STS, neurological injury, and surgery were positively correlated with PTB (P < 0.05). The cure rate did not differ significantly between patients with and without PTB (P > 0.05).

Table 4: Correlation analysis between STB and PTB.

Variate
Type
Without PTB
With PTB
Total
χ2
P

N
%
N
%

Gender
Male
573
56.6
232
63.4
805
5.068
0.024

Female
439
43.4
134
36.6
573

Abscess
Yes
644
63.6
259
70.8
903
6.047
0.014

No
368
36.4
107
29.2
475

Surgery
Yes
776
76.7
224
61.2
1000
32.347
0.000

No
236
23.3
142
38.8
378

Systemic toxicity symptoms
Yes
305
30.1
138
37.7
443
7.055
0.008

No
707
69.9
228
62.3
935

Neurological injury
Yes
480
47.4
207
56.6
687
8.955
0.003

No
532
52.6
159
43.4
691

Prognosis
Cure
891
88.0
319
87.2
1214
0.490
0.484

Others
121
12.0
47
12.8
163

Of the patients with concomitant diabetes, 87.3% were middle-aged or older, 44.4 % had STS, 46.0% required non-surgical treatment only, and the cure rate was 76.2% (Table 5). Age, STS, surgery and prognosis were correlated with the presence of diabetes (P < 0.05).

Table 5: Correlation analysis between STB and diabetes.

Variate
Type
Without diabetes
With diabetes
Total
χ2
P

N
%
N
%

Age (yeas)
>45
662
50.3
55
87.3
717
32.904
0.000

≦45
653
49.7
8
12.7
661

Systemic toxicity symptoms
Yes
415
31.6
28
44.4
443
4.576
0.032

No
900
68.4
35
55.6
935

Surgery
Yes
966
73.4
34
54.0
1000
11.474
0.001

No
349
26.6
29
46.0
378

Prognosis
Cure
1167
88.7
48
76.2
1215
9.086
0.003

Others
148
11.3
15
23.8
163

3.6. Comparison of Data according to Time Period

Comparisons of data in the first and second group of 5 years are shown in Table 6. Group A (January 2007–December 2011) comprised 654 patients and Group B (January 2012–December 2016) 724. There was a greater proportion of patients aged over 60 years, urban patients, and medical staff with STB in Group B than in Group A (P < 0.05), the proportion of older patients, urban patients, and medical staff with STB having increased by 6.1%, 5.2%, and 1.3%, respectively.

Table 6: Comparison of 10 years' data.

Variate
Type
Group A
Group B
Total
χ2
P

(2007-2011)
(2012-2016)

N
%
N
%

Gender
Male
378
57.8
427
59
805
0.197
0.657

Female
276
42.2
297
41
573

Age (yeas)
≦60
526
80.4
538
74.3
1064
7.312
0.007

>60
128
19.6
186
25.7
314

Residence
Rural
494
75.5
509
70.3
1003
4.747
0.029

Urban
160
24.5
215
29.7
375

Occupation
Medical staff
6
0.9
16
2.2
22
4.154
0.046

Others
648
99.1
708
97.8
1356

Back pain
Yes
596
91.1
679
93.8
1275
3.497
0.061

No
58
8.9
45
6.2
103

Radicular pain
Yes
264
40.4
288
39.6
552
0.049
0.825

No
390
59.6
436
60.4
826

Systemic toxicity symptoms
Yes
215
32.9
228
31.5
443
0.301
0.583

No
439
67.1
496
68.5
935

Abscess
Yes
429
65.6
474
65.5
903
0.002
0.964

No
225
34.4
250
34.5
475

Neurological injury
Yes
339
51.8
348
48.1
687
1.952
0.162

No
315
48.2
376
51.9
691

Involved number of vertebrae
<3
509
77.8
549
75.9
1058
0.771
0.380

≧3
145
22.2
175
24.1
320

Surgery
Yes
488
68.5
512
70.7
1000
2.625
0.105

No
166
31.5
212
29.3
378

PTB
Yes
176
26.9
190
26.2
366
0.079
0.779

No
478
73.1
534
73.8
1012

Diabetes
Yes
23
3.5
40
5.5
63
3.176
0.075

No
631
96.5
684
94.5
1315

Prognosis

Cure
567
86.7
648
89.5
1215
2.593
0.107

Others
87
13.3
76
11.9
163

4. Discussion

According to a 2017 WHO report [1], 603,000 male and 292,000 female patients were newly diagnosed with TB in China, this male to female ratio being 2.1:1. In the present study, the male to female ratio of the 1378 patients with STB was 1.4:1, and there was no significant change in that ratio over the 10 years of the study. Young and middle-aged adults (18–60 years old) accounted for 1378 (69.9%) of the patients with STB. This age group provides the main labor force, which is important in that long-term physical labor increases the load on and activity of the spine, resulting in chronic spinal damage, thus increasing susceptibility to MTB. Children had the lowest incidence (7.3%), which may be attributable to the protective effect of BCG inoculation, which is sustained into adolescence [7].

In 2010, the fifth national TB survey showed an increase in the number of older patients with bone and joint TB [8], and in the present study we found that the number of patients aged >60 years increased significantly over time. This increase in older patients may be associated with the aging of the general population [9], lengthening lifespans, poor immunological function, and the increased number of comorbidities in this age group [10]. In addition, STB in older persons is characterized by complexity, disease, slow recovery, resistance to treatment, and atypical symptoms [11]. This trend has hampered developments in public health and social conditions and increased difficulties in prevention and treatment of STB.

Worldwide, 80% of patients with STB are in developing countries and poverty-stricken areas. In China, 80% of patients with STB are in rural areas [8]. In this study, 72.8% patients were from rural areas, which are associated with poor economic level and poor medical and health conditions. The proportion of urban patients with STB increased from 24.5% to 29.7% between the two five-year periods of the present study; this may be related to the increasing proportion of Chinese persons in urban areas. Developments in transportation and increases in population mobility may have contributed to this change. We identified more patients with STB in Changsha, Shaoyang, Yueyang, and Yiyang than in other cities of Hunan province. Possible reasons for this discrepancy may include comprehensive factors affecting the availability of treatment, the population of each city, and variations in economic situation between regions. Thus, screening for STB is recommended for improving prevention, early diagnosis, and treatment of STB in the cities with a high incidence of this condition.

In this study, 66.6% of the patients were farmers and manual workers, who had been engaging in stooped labor, which may increase the prevalence of STB. It is worth noting that the incidence of medical staff increased significantly (P < 0.05) over the 10 years of the study. Medical staff are exposed to patients with diagnosed or suspected TB, which confers a high risk of TB infection [12].

Back pain is the most frequent symptom of STB [13]. Such pain is typically localized to the site of involvement, which is most commonly the thoracic and lumbar spine. In one study, chronic back pain was the only symptom in 61% of patients with STB [3]. In the present study, 92.5% of inpatients had pain at the site of lesion and this was the main reason for patients seeking medical evaluation and treatment. The mechanisms by which STB causes pain are as follows. First, pain may be caused by spinal instability due to destruction of the vertebral body. Second, neuropathic pain may result from inflammatory stimuli associated with TB lesions, such as abscesses and necrotic bone. Radicular pain was present in 40.1% of our patients as a result of inflammatory stimuli of nerve root. STS of TB, indicating presence of active disease, are present in approximately of patients with osteoarticular TB [13]. In this study, 32.1% of patients presented with STS of TB, including low fever, fatigue, emaciation, and night sweats. High fever may also occur during the acute phase of TB. Typical STS of TB can contribute to the diagnosis of STB; however, 67.9% of our patients lacked such symptoms.

STB is prone to cause neurological injury and the rate of disability is high. The incidence of neurological impairment in patients with STB reportedly varies from 23% to 76% [14]. In this study, 49.9% patients had neurologic impairment, 1.5% of them having ASIA Grade A and 2.8% Grade B, which represent severe neurologic damage. Patients with STB and neurologic impairment often need surgical treatment to create space to enable nerve recovery. Impaired neural function can recover to different degrees after surgery; however, recovery in patients with severe neurologic impairment is characteristically poor.

STB often involves two vertebrae because the segmental arteries bifurcate to supply two adjacent vertebrae. Spread of MTB beneath the anterior or posterior longitudinal ligaments can also result in involvement of multiple contiguous vertebrae. In this study, 67.9% of patients had two involved adjacent vertebrae, which comprised one motion segment. The most frequently involved vertebrae were lumbar, followed by thoracic. This localization may be related to the anatomical factors of high level of mobility and load forces in the lumbar region and the long segments in the thoracic region. The incidence was only 0.8% in sacrococcygeal vertebrae, likely because of its short segments, low mobility, and low load forces. Abscess formation around a vertebral lesion, which is not uncommon and prone to extreme enlargement, is another characteristic feature of STB. In this study, 65.5% of patients had abscesses. The 34.5% without abscesses may be more difficult to diagnose. Differential diagnoses include other diseases that cause bone destruction, such as spinal tumors.

Anti-TB drug treatment is the gold standard for the treatment of STB, whereas surgical treatment plays an important role as adjuvant therapy. The aim of surgery is to completely remove a lesion, achieve spinal decompression, reconstruct spinal stability, and restore a normal spinal sequence [15]. In this study, 72.6% of inpatients underwent surgery and their cure rate was as high as 88.2%. The relapse rate was 3.5% (49 patients). Reasons for recurrence may include erratic anti-TB drug treatment, malnutrition, comorbidities, and inadequate rest. The patients with relapses were all cured by revision surgery, including debridement, drainage, and focal catheter infusion with anti-TB drugs.

Five percent of patients with PTB reportedly have accompanying STB [16, 17]. Approximately 33%–50% of patients with STB have an associated primary lung focus or report a history of PTB [18]. In our study, 26.6% of patients with STB had accompanying PTB. We found that concomitant STB and PTB had the following characteristics. This combination was more common in male patients and was associated with abscesses, STS, neurological injury, and non-operative treatment. The influence of smoking, drinking and other lifestyle factors [19] may account for the predominance of PTB in men. Given that the STS of fever and night sweats are commonly present in patients with PTB, it is unsurprising that they are also common in patients with STB and PTB. The probability of abscess and neurological injury may be related to the extent of lesion; the specific reasons need further study. Patients with STB complicated by active PTB are prone to undergo conservative treatment. Surgery may cause spread of MTB.

The prevalence of TB was three to six times higher in patients with diabetes than in those without diabetes; additionally, the incidence of TB was three times higher in patients with poorly controlled diabetes than in those with ideally controlled diabetes [20]. Active TB, being an infection, can aggravate diabetes and may even induce acute ketoacidosis. Patients with diabetes and TB usually have the characteristics of long course, severe illness, rapid progression, and slow rehabilitation, which make treatment difficult [21, 22]. Moreover, patients with diabetes and STB have impaired anti-infection and tissue repair ability. Internal fixation and implants [23] are often needed for STB surgery. Active infection often exacerbates the patient’s condition and affects the prognosis, sometimes leading to failure of surgery [24]. In our study, 63 patients (4.6%) had accompanying diabetes. We found that patients with STB and diabetes had the following characteristics. They were more commonly aged over 45 years and were prone to have STS and undergo non-surgical treatment. In addition, their prognosis was relatively poor. If surgery is needed in these patients, attention should be paid to the following: infection, wound healing [25], osteoporosis [26], stability of internal fixation [27] and vascular lesions [28].

The following limitations of this study are worth noting. First, the number of patients was relatively small and they were all inpatients. Because data on them is inadequate and difficult to obtain, outpatients were not included in this study; this may have resulted in a bias in outcomes, such as the higher rate of surgery and no HIV/AIDS case. Second, results of tests for drug resistance were unavailable.

5. Conclusions

STB remains a severe problem endangering the public health and cannot be ignored. Most patients ignore its symptoms and therefore receive untimely treatment. Thus, surveillance for and treatment of STB should be strengthened in south-central China. In addition to the existing database for PTB, a database of patients with STB should be set up throughout China.

Data Availability

The data used to support the findings of this study are included within the article.

Conflicts of Interest

The authors declare that they have no conflicts of interests.

Authors’ Contributions

Zheng Liu and Jun Wang contributed equally to the work as first authors.

Acknowledgments

The work was supported by the National Natural Science Foundation of China (No. 81672191), Clinical scientific research funds of Xiangya hospital (2016L07), and Independent exploration and innovation project for postgraduates of central south university (2019). No benefit in any form has been or will be received from a commercial party related directly or indirectly to the subject of this manuscript.

References

WHO, Global Tuberculosis Report 2018, World Health Organization (WHO), 2018.

C. Pigrau-Serrallach and D. Rodríguez-Pardo, “Bone and joint tuberculosis,” European Spine Journal, vol. 71, no. 3, pp. 556–566, 2013.

L. Cormican, R. Hammal, J. Messenger, and H. J. Milburn, “Current difficulties in the diagnosis and management of spinal tuberculosis,” Postgraduate Medical Journal, vol. 82, no. 963, pp. 46–51, 2006.

H. Zeng, X. Shen, C. Luo et al., “360-degree cervical spinal arthrodesis for treatment of pediatric cervical spinal tuberculosis with kyphosis,” BMC Musculoskeletal Disorders, vol. 17, no. 1, pp. 1–10, 2016.

L.-J. Wang, H.-Q. Zhang, M.-X. Tang, Q.-L. Gao, Z.-H. Zhou, and X.-H. Yin, “Comparison of three surgical approaches for thoracic spinal tuberculosis in adult: minimum 5-year follow up,” The Spine Journal, vol. 42, no. 11, pp. 808–817, 2017.

M. Fukui, K. Chiba, M. Kawakami et al., “Japanese orthopaedic association cervical myelopathy evaluation questionnaire (JOACMEQ): part 4. establishment of equations for severity scores: subcommittee on low back pain and cervical myelopathy, evaluation of the clinical outcome committee of the Japanese orthopaedic association,” Journal of Orthopaedic Science, vol. 13, no. 1, pp. 25–31, 2008.

K. X. Mao, C. X. Zhen, L. H. Yan, Q. Dan, M. X. Wang, and C. Y. Zhang, “Protective effect of vaccination of bacille Calmette-Guerin on children,” Chinese Journal of Contemporary Pediatrics, vol. 5, no. 4, pp. 325–327, 2003.

Technical Guidance Group of the Fifth National TB Epidemiological Survey The Office of the Fifth National TB Epidemiological Survey, “The fifth national tuberculosis epidemiological survey in 2010,” Chinese Journal of Antituberculosis, 2012.

G. Ding, H. Wu, and H. Wang, “The diagnosis and treatment of senile tuberculosis of spine,” Journal of Wannan Medical College, 2000.

X. Chen, Q. Wang, and J. Ma, “Clinical analyses of spinal tuberculosis in older patients,” Orthopaedic Biomechanics Materials & Clinical Study, 2015.

Z. Liu, X. Wang, Z. Xu et al., “Two approaches for treating upper thoracic spinal tuberculosis with neurological deficits in the elderly: A retrospective case-control study,” Clinical Neurology and Neurosurgery, vol. 141, pp. 111–116, 2016.

G. X. He, S. V. D. Hof, M. J. V. D. Werf et al., “Infection control and the burden of tuberculosis infection and disease in health care workers in China: a cross-sectional study,” BMC Infectious Diseases, vol. 10, no. 1, article no. 313, 2010.

R. K. Garg and D. S. Somvanshi, “Spinal tuberculosis: a review,” The Journal of Spinal Cord Medicine, vol. 34, no. 5, pp. 440–454, 2011.

K. Kotil, M. S. Alan, and T. Bilge, “Medical management of Pott disease in the thoracic and lumbar spine: A prospective clinical study,” Journal of Neurosurgery: Spine, vol. 6, no. 3, pp. 222–228, 2007.

Z. Liu, P. Zhang, H. Zeng, Z. Xu, and X. Wang, “A comparative study of single-stage transpedicular debridement, fusion, and posterior long-segment versus short-segment fixation for the treatment of thoracolumbar spinal tuberculosis in adults: minimum five year follow-up outcomes,” International Orthopaedics, vol. 42, no. 8, pp. 1883–1890, 2018.

M. P. Gautam, P. Karki, S. Rijal, and R. Singh, “Pott's spine and paraplegia,” JNMA; Journal of the Nepal Medical Association, vol. 44, no. 159, p. 106, 2005.

M. Turgut, “Spinal tuberculosis (Pott's disease): Its clinical presentation, surgical management, and outcome. A survey study on 694 patients,” Neurosurgical Review, vol. 24, no. 1, pp. 8–13, 2001.

P. Schirmer, C. A. Renault, and M. Holodniy, “Is spinal tuberculosis contagious?” International Journal of Infectious Diseases, vol. 14, no. 8, pp. e659–e666, 2010.

B. Dong, N. Ge, and G. Liu, “Social economical status, behaviors and environment as the risk factors of tuberculosis in Chengdu China,” Chinese Journal of Epidemiology, vol. 22, no. 2, p. 102, 2001.

S. Lin, M. Shen, and Y. Sun, “Epidemiological characteristics of tuberculosis patients complicated with diabetes in Shanghai,” Chinese Journal of Tuberculosis & Respiratory Diseases, vol. 21, no. 8, p. 504, 1998.

X.-H. Wang, “Clinical observation of Type II diabetes complicated with pulmonary tuberculosis,” Journal of Clinical Pulmonary Medicine, 2006.

L. I. Bingxi, “Clinical analysis of cases suffer from pulmonary tuberculosis related diabetes,” Journal of Medical Forum, 2008.

Y. X. Wang, H. Q. Zhang, W. Liao et al., “One-stage posterior focus debridement, interbody graft using titanium mesh cages, posterior instrumentation and fusion in the surgical treatment of lumbo-sacral spinal tuberculosis in the aged,” International Orthopaedics, vol. 40, no. 6, pp. 1117–1124, 2016.

S. Chen, M. V. Anderson, W. K. Cheng, and M. D. Wongworawat, “Diabetes associated with increased surgical site infections in spinal arthrodesis,” Clinical Orthopaedics and Related Research, vol. 467, no. 7, pp. 1670–1673, 2009.

H. E. Wei-Dong, K. E. Chu-Qun, and Y. Q. Lin, “Perioperative management of orthopaedic disease patients with diabetes mellitus,” Orthopedic Journal of China, 2005.

K. Wongdee and N. Charoenphandhu, “Osteoporosis in diabetes mellitus: possible cellular and molecular mechanisms,” World Journal of Diabetes, vol. 2, no. 3, pp. 41–48, 2011.

K. Okuyama, K. Sato, E. Abe, H. Inaba, Y. Shimada, and H. Murai, “Stability of transpedicle screwing for the osteoporotic spine: an in vitro study of the mechanical stability,” The Spine Journal, vol. 18, no. 15, pp. 2240–2245, 1993.

H. E. Yan and Tang Y. P., “Progress in researches on diabetes combined with thrombus and thromboembolic disease,” Practical Journal of Clinical Medicine, 2012.